Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
home:othertreatments:birth_control [09.21.2011]
paulalbert
home:othertreatments:birth_control [01.03.2012] (current)
Line 3: Line 3:
 <​relatedarticles>​ [[home:​special:​pregnancy|Pregnancy and fertility]],​ [[home:​othertreatments:​female_hormones|Female hormone supplementation]] </​article>​ <​relatedarticles>​ [[home:​special:​pregnancy|Pregnancy and fertility]],​ [[home:​othertreatments:​female_hormones|Female hormone supplementation]] </​article>​
  
-Women of childbearing age on the MP who do not want to risk the chance of bearing a child suffering from fetal and neonatal injury, including hypotension,​ neonatal skull hypoplasia, anuria, reversible or irreversible renal failure, etc. should take precautions to prevent pregnancy, as the FDA package insert lists these as complications of taking olmesartan during the second or third trimesters. According to the FDA, these adverse effects do not appear to have resulted from intrauterine drug exposure that has occurred only during the first trimester.+Women of childbearing age on the MP who do not want to risk the chance of bearing a child suffering from fetal or neonatal injury should take precautions to prevent pregnancy, as the FDA package insert lists these as complications of taking olmesartan during the second or third trimesters. According to the FDA, these adverse effects do not appear to have resulted from intrauterine drug exposure that has occurred only during the first trimester.
  
 Because the MP can increase or restore fertility, women of childbearing age who are on the MP and sexually active are advised to use adequate precautions to avoid getting pregnant. Because the MP can increase or restore fertility, women of childbearing age who are on the MP and sexually active are advised to use adequate precautions to avoid getting pregnant.
Line 72: Line 72:
 PMID: 9627916</​blockquote>​ PMID: 9627916</​blockquote>​
  
-EDIT+
home/othertreatments/birth_control.txt · Last modified: 01.03.2012 (external edit)
© 2015, Autoimmunity Research Foundation. All Rights Reserved.